Hee-Dong Kim
Oprichter bij Kingsley Ventures
Profiel
Hee-Dong Kim is the founder of Kingsley Capital Partners LLP, a firm he founded in 2013 where he currently holds the title of senior advisor.
He is also the founder of Kingsley Ventures.
Mr. Kim's current jobs include being an Executive Director at Forma Holdings and a Director at Mcqueens Flowers Ltd.
Mr. Kim's former jobs include being a Director at Oxford Cannabinoid Technologies Ltd.
from 2017 to 2021 and an Investment Manager at Invision AG from 2009 to 2015.
Actieve functies van Hee-Dong Kim
Bedrijven | Functie | Begin |
---|---|---|
Kingsley Capital Partners LLP
Kingsley Capital Partners LLP Investment ManagersFinance Kingsley Capital Partners LLP (KCP) is a private equity and venture capital firm. The company was founded by Hee-Dong Kim and Neil Mahapatra in 2013 and is headquartered in London, the United Kingdom. | Consultant / Adviseur | 01-01-2023 |
Forma Holdings
Forma Holdings Miscellaneous Commercial ServicesCommercial Services Forma Holdings builds businesses in legal medical cannabis markets around the world. The company was founded by Tarek K. Tabsh in 2016 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | - |
Kingsley Ventures
Kingsley Ventures Investment ManagersFinance Kingsley Ventures is a venture capital arm of Kingsley Capital Partners LLP founded by Hee-Dong Kim and Neil Mahapatra in 2013. The firm is headquartered in London. | Oprichter | - |
Mcqueens Flowers Ltd.
Mcqueens Flowers Ltd. Specialty StoresRetail Trade Mcqueens Flowers Ltd. retails flowers. The company was founded in 1991 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 14-08-2017 |
Eerdere bekende functies van Hee-Dong Kim
Bedrijven | Functie | Einde |
---|---|---|
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Directeur/Bestuurslid | 21-05-2021 |
Invision AG /CH/
Invision AG /CH/ Investment ManagersFinance Invision AG (formerly Invision Private Equity) is an independent Swiss private equity firm which was founded in 1997 as the corporate venture capital division of Metro Holding. In 2000, Invision completed a spin-off from Metro and merged with Aureus Private Equity. Headquartered in Zug, the firm manages the Invision private equity funds, backed by pension funds, family offices, fund of funds, other financial institutions and private individuals. Invision's network of advisers provides industry expertise, resources, specializations and access to renowned industry experts that support the firm in the selection and value creation process. | Private Equity Investor | 31-12-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Invision AG /CH/
Invision AG /CH/ Investment ManagersFinance Invision AG (formerly Invision Private Equity) is an independent Swiss private equity firm which was founded in 1997 as the corporate venture capital division of Metro Holding. In 2000, Invision completed a spin-off from Metro and merged with Aureus Private Equity. Headquartered in Zug, the firm manages the Invision private equity funds, backed by pension funds, family offices, fund of funds, other financial institutions and private individuals. Invision's network of advisers provides industry expertise, resources, specializations and access to renowned industry experts that support the firm in the selection and value creation process. | Finance |
Kingsley Capital Partners LLP
Kingsley Capital Partners LLP Investment ManagersFinance Kingsley Capital Partners LLP (KCP) is a private equity and venture capital firm. The company was founded by Hee-Dong Kim and Neil Mahapatra in 2013 and is headquartered in London, the United Kingdom. | Finance |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Forma Holdings
Forma Holdings Miscellaneous Commercial ServicesCommercial Services Forma Holdings builds businesses in legal medical cannabis markets around the world. The company was founded by Tarek K. Tabsh in 2016 and is headquartered in London, the United Kingdom. | Commercial Services |
Kingsley Ventures
Kingsley Ventures Investment ManagersFinance Kingsley Ventures is a venture capital arm of Kingsley Capital Partners LLP founded by Hee-Dong Kim and Neil Mahapatra in 2013. The firm is headquartered in London. | Finance |
Mcqueens Flowers Ltd.
Mcqueens Flowers Ltd. Specialty StoresRetail Trade Mcqueens Flowers Ltd. retails flowers. The company was founded in 1991 and is headquartered in London, the United Kingdom. | Retail Trade |